Skip to main content
PatentCliff

Prior Art

Any evidence that an invention was already known or publicly available before a patent application was filed.

What It Means

Prior art is the body of existing knowledge that patent examiners use to determine whether an invention is truly novel and non-obvious. It includes previously granted patents, published patent applications, academic papers, conference presentations, products sold on the market, public demonstrations, and even oral disclosures, essentially anything that was publicly available before the patent application's filing date. When a patent examiner reviews an application, they search prior art databases to find references that describe the same or similar inventions. If prior art shows that the invention was already known, the claims will be rejected for lack of novelty. If prior art shows components that could be combined to arrive at the invention, the claims may be rejected as obvious. Prior art searches are also critical in patent litigation: defendants accused of infringement frequently argue that the patent should never have been granted because the examiner missed relevant prior art. This is the basis for invalidation defenses and inter partes review proceedings. Companies investing in R&D conduct their own prior art searches before filing to avoid wasting money on applications likely to be rejected. Patent attorneys use prior art strategically, both to strengthen their own applications by distinguishing from existing work, and to challenge competitors' patents by finding references the original examiner may have missed. The completeness of prior art searching directly affects the quality and defensibility of issued patents.

Frequently Asked Questions

What does Prior Art mean?

Any evidence that an invention was already known or publicly available before a patent application was filed.

Why is prior art important in patent law?

Prior art is the body of existing knowledge that patent examiners use to determine whether an invention is truly novel and non-obvious. It includes previously granted patents, published patent applications, academic papers, conference presentations, products sold on the market, public demonstrations...

this entity is one of the U.S. pharmaceutical patent expirations concepts that recurs across this site. The definition above is the technical answer; the paragraphs below add the practical context for how the concept connects to the the FDA Orange Book and USPTO patent records data behind every per-entity page on the site.

In the the FDA Orange Book and USPTO patent records data, this concept shapes one or more of the fields that drive the per-entity grades and rankings on this site. The methodology page describes which fields feed into which output; this glossary entry documents the underlying term.

Source: USPTO patent search, 2026.